N-[3-bromo-2-chloro-4-(4, 5-dihydro-1H-imidazol-2-ylmethyl)-phenyl] - methanesulfoamide as alpha-1 A adrenergic partial agonist for the treatment of incontinence

This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing formula I, methods for their use as therapeutic agents, and methods o...

Full description

Saved in:
Bibliographic Details
Main Authors COUNDE O'YANG, DENNIS MITSUGU YASUDA
Format Patent
LanguageEnglish
Published 13.08.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing formula I, methods for their use as therapeutic agents, and methods of preparation thereof.
Bibliography:Application Number: AU20090211504